Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion

Clinical and Experimental Metastasis

Volumn 32, Issue 5, 2015, Pages 467-478

  Pedrola, Núria ^a   Devis, Laura ^a   Llauradó, Marta ^a   Campoy, Irene ^a   Martinez Garcia, Elena ^a   Garcia, Marta ^a   Muinelo Romay, Laura ^b   Alonso Alconada, Lorena ^b   Abal, Miguel ^b   Alameda, Francesc ^c   Mancebo, Gemma ^c   Carreras, Ramon ^c   Castellví, Josep ^d   Cabrera, Sílvia ^d   Gil Moreno, Antonio ^d   Matias Guiu, Xavier ^e   Iovanna, Juan L ^f   Colas, Eva ^a,e   Reventós, Jaume ^a,g   Ruiz, Anna ^a,h  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL ARNAU DE VILANOVA   (Spain)

^f AIX MARSEILLE UNIVERSITY   (France)

^g UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^h Servicio de Oncología Médica   (Spain)

Author keywords

Endometrial cancer; ETV5; Invasion; NID1; NUPR1

Indexed keywords

COLLAGEN TYPE 1; ENTACTIN; LAMININ; MESSENGER RNA; NIDOGEN 1; NUCLEAR PROTEIN; NUCLEAR PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV5; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; ETV5 PROTEIN, HUMAN; LUCIFERASE; MEMBRANE PROTEIN; P8 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIUM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DRUG SCREENING; ENDOMETRIUM TUMOR; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930572227     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-015-9720-7     Document Type: Article

References (31)

1. Amant F, Moerman P, Neven P et al (2005) Endometrial cancer. Lancet 366:491–505. doi:10.1016/S0140-6736(05)67063-8
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30. doi:10.3322/caac.21166
3. Colas E, Pedrola N, Devis L et al (2012) The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 14:715–720. doi:10.1007/s12094-012-0866-3
4. Tanaka Y, Terai Y, Kawaguchi H et al (2013) Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther 14:13–19. doi:10.4161/cbt.22625
5. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454. doi:10.1038/nrc822
6. Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15–33. doi:10.1007/s10555-008-9169-0
7. Planagumà J, Gonzalez M, Doll A et al (2006) The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma. Hum Pathol 37:1050–1057. doi:10.1016/j.humpath.2006.03.007
8. Planagumà J, Abal M, Gil-Moreno A et al (2005) Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. J Pathol 207:422–429. doi:10.1002/path.1853
9. Monge M, Colas E, Doll A et al (2007) ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 67:6753–6759. doi:10.1158/0008-5472.CAN-06-4487
10. Colas E, Muinelo-Romay L, Alonso-Alconada L et al (2012) ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. Oncogene 31:4778–4788. doi:10.1038/onc.2011.632
11. Creasman WT, Odicino F, Maisonneuve P et al (2006) Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 95(Suppl 1):S105–S143. doi:10.1016/S0020-7292(06)60031-3
12. Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 105:109. doi:10.1016/j.ijgo.2009.02.010
13. Llauradó M, Majem B, Castellví J et al (2012) Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer. Mol Cancer Res MCR 10:914–924. doi:10.1158/1541-7786.MCR-11-0449
14. Llauradó M, Abal M, Castellví J et al (2012) ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells. Int J Cancer J Int Cancer 130:1532–1543. doi:10.1002/ijc.26148
15. Sandi MJ, Hamidi T, Malicet C et al (2011) p8 expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis. J Cell Physiol 226:3442–3451. doi:10.1002/jcp.22702
16. Muinelo-Romay L, Colas E, Barbazan J et al (2011) High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion. Mol Cancer Ther 10:1357–1366. doi:10.1158/1535-7163.MCT-10-1019
17. Cabrera S, Llauradó M, Castellví J et al (2012) Generation and characterization of orthotopic murine models for endometrial cancer. Clin Exp Metastasis 29:217–227. doi:10.1007/s10585-011-9444-2
18. Chung AE, Dong LJ, Wu C, Durkin ME (1993) Biological functions of entactin. Kidney Int 43:13–19
19. Kopfstein L, Christofori G (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci CMLS 63:449–468. doi:10.1007/s00018-005-5296-8
20. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429–447. doi:10.1002/path.1398
21. Talbot LJ, Bhattacharya SD, Kuo PC (2012) Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol 3:117–136
22. Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009. doi:10.1016/j.cell.2011.11.016
23. Brannon KM, Million Passe CM, White CR et al (2007) Expression of the high mobility group A family member p8 is essential to maintaining tumorigenic potential by promoting cell cycle dysregulation in LbetaT2 cells. Cancer Lett 254:146–155. doi:10.1016/j.canlet.2007.03.011
24. Hamidi T, Cano CE, Grasso D et al (2012) Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin Cancer Res Off J Am Assoc Cancer Res 18:5234–5246. doi:10.1158/1078-0432.CCR-12-0026
25. Goruppi S, Iovanna JL (2010) Stress-inducible protein p8 is involved in several physiological and pathological processes. J Biol Chem 285:1577–1581. doi:10.1074/jbc.R109.080887
26. Jiang WG, Davies G, Martin TA et al (2006) Com-1/p8 acts as a putative tumour suppressor in prostate cancer. Int J Mol Med 18:981–986
27. Du P, Ye L, Yang Y, Jiang WG (2013) Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells. Int J Oncol 42:1249–1256. doi:10.3892/ijo.2013.1802
28. Aumailley M, Battaglia C, Mayer U et al (1993) Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 43:7–12
29. Hopf M, Göhring W, Kohfeldt E et al (1999) Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin. Eur J Biochem FEBS 259:917–925
30. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239–252. doi:10.1038/nrc2618
31. Vasseur S, Hoffmeister A, Garcia-Montero A et al (2002) p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21:1685–1694. doi:10.1038/sj.onc.1205222